Yong X. Su
519 East Beijing Road
Nanchang, 330029, China
Nanchang, 330029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Overlap-adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator.
Journal: Practical radiation oncology
Published: April 27, 2026
Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy.
Journal: Frontiers in oncology
Published: August 28, 2025
Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma.
Journal: ImmunoTargets and therapy
Published: January 15, 2025
Integrated Early CRP Kinetics and Plasma EBV DNA Clearance as Prognostic Biomarkers in De Novo Metastatic Nasopharyngeal Carcinoma Treated with First-Line Chemoimmunotherapy.
Journal: Journal of inflammation research
Published: January 12, 2025
HMMR mediates progression of nasopharyngeal carcinoma by inhibiting FAM83D ubiquitination and activating beta-catenin signaling pathway.
Journal: Scientific reports
Published: December 21, 2024
Efficacy and Failure Patterns Following Target Volume and Dose Reduction After Neoadjuvant Therapy in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Journal: Head & neck
Published: October 26, 2024
Advancing precise diagnosis of nasopharyngeal carcinoma through endoscopy-based radiomics analysis.
Journal: iScience
Published: April 30, 2024
PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes.
Journal: Frontiers in immunology
Published: December 10, 2023
Last Updated: 09/26/2026